M&A Deals Roundup: Expedia, Sanofi, Zuora, Forward Air and More
Sector Update: Health Care Stocks Advance Late Afternoon
Sector Update: Health Care
Sanofi Aims to Sign Consumer Health Sales Pact With CD&R Shortly, Bloomberg Says
'Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend' - Bloomberg
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
Sanofi Receives Higher Offer From PAI Partners for Opella After Deadline Lapses
J.P. Morgan Reaffirms Their Hold Rating on Sanofi (SNYNF)
PAI Partners Raises Offer for Sanofi's Consumer Unit - Reports
Response Pharmaceuticals Announces Enrollment of First Patients in a Phase 2 Study Evaluating RDX-002, a Novel Small Molecule IMTP Inhibitor, in Patients Discontinuing GLP-1 Agonists & Clinical Presentation at Obesity Week
UBS Remains a Buy on Sanofi (SNYNF)
Exscientia Advances Two Additional Discovery Programs With Sanofi
Sanofi in Talks With French Government Over Opella Sale, WSJ Says
Sanofi's Strong Market Position and Growth Potential Justifies Buy Rating
Press Release: Sanofi and Orano Join Forces to Develop Next-generation Radioligand Medicines
Sanofi Gets FDA Approval to Update Flu Vaccine Label With New Pregnancy Safety Data
Goldman, Citi Among 22 Banks on CD&R's Buyout of Sanofi Unit
FDA Updates U.S. Label for Sanofi's FLUBLOK
Sanofi Unions to Strike in France Over Proposed Unit Sale: Report
Sanofi (SNY.US) caught in a strike storm! $16 billion Opella sale case attracts French government intervention.
French unions have organized Sanofi workers to strike starting from Thursday to protest the company's plan to sell its consumer health division, Opella.